Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126426031 | 12642603 | 1 | I | 20160615 | 20160620 | 20160810 | 20160810 | PER | US-ASTRAZENECA-2016SE68247 | ASTRAZENECA | 18102.00 | DY | F | Y | 77.10000 | KG | 20160811 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126426031 | 12642603 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 250 MCG/1.2 ML , 5MCG PEN TWICE A DAY | U | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
| 126426031 | 12642603 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | OFF AND ON FOR 2 YEARS | U | 19810 | TABLET | ||||||||
| 126426031 | 12642603 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 19810 | 1 | DF | TABLET | QD | ||||||
| 126426031 | 12642603 | 4 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 0 | 10 | MG | BID | ||||||||
| 126426031 | 12642603 | 5 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 0 | |||||||||||
| 126426031 | 12642603 | 6 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 0 | |||||||||||
| 126426031 | 12642603 | 7 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | |||||||||||
| 126426031 | 12642603 | 8 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | |||||||||||
| 126426031 | 12642603 | 9 | C | DIABETIC VITAMIN PACK | 2 | Oral | 8 PILLS A DAY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126426031 | 12642603 | 1 | Type 2 diabetes mellitus |
| 126426031 | 12642603 | 2 | Gastrooesophageal reflux disease |
| 126426031 | 12642603 | 3 | Gastrooesophageal reflux disease |
| 126426031 | 12642603 | 4 | Type 2 diabetes mellitus |
| 126426031 | 12642603 | 5 | Headache |
| 126426031 | 12642603 | 6 | Pain |
| 126426031 | 12642603 | 7 | Headache |
| 126426031 | 12642603 | 8 | Pain |
| 126426031 | 12642603 | 9 | Vitamin B complex deficiency |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126426031 | 12642603 | Blood glucose increased | |
| 126426031 | 12642603 | Circumstance or information capable of leading to medication error | |
| 126426031 | 12642603 | Drug dose omission | |
| 126426031 | 12642603 | Injection site pain | |
| 126426031 | 12642603 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126426031 | 12642603 | 1 | 20160613 | 0 | ||
| 126426031 | 12642603 | 4 | 201605 | 0 |